171 related articles for article (PubMed ID: 1449017)
1. Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid.
Güldütuna S; Leuschner U; Imhof M; Zimmer G
Z Gastroenterol; 1992 Mar; 30 Suppl 1():49-54. PubMed ID: 1449017
[TBL] [Abstract][Full Text] [Related]
2. Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
Lirussi F; Okolicsanyi L
Ital J Gastroenterol; 1992 Jan; 24(1):31-5. PubMed ID: 1571577
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis.
Simko V; Michael S; Prego V
Am J Gastroenterol; 1994 Mar; 89(3):392-8. PubMed ID: 8122652
[TBL] [Abstract][Full Text] [Related]
5. [Bile acids in liver diseases--current indications].
Stiehl A
Ther Umsch; 1995 Oct; 52(10):682-6. PubMed ID: 7482380
[TBL] [Abstract][Full Text] [Related]
6. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
[TBL] [Abstract][Full Text] [Related]
7. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of cholestatic liver diseases; the role of ursodeoxycholic acid].
Stiehl A
Z Gastroenterol; 1992 Oct; 30(10):743-7. PubMed ID: 1441678
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis.
Yamazaki K; Suzuki K; Nakamura A; Sato S; Lindor KD; Batts KP; Tarara JE; Kephart GM; Kita H; Gleich GJ
Hepatology; 1999 Jul; 30(1):71-8. PubMed ID: 10385641
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late stage disease.
Kneppelhout JC; Mulder CJ; van Berge Henegouwen GP; de Vries RA; Brandt KH
Neth J Med; 1992 Aug; 41(1-2):11-6. PubMed ID: 1407234
[TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
[TBL] [Abstract][Full Text] [Related]
13. [Drug therapy of cholestatic hepatopathies].
Leuschner U
Schweiz Rundsch Med Prax; 1992 Aug; 81(34):983-4. PubMed ID: 1529191
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis.
Wouters RS; Bos LP; Engels LG
Neth J Med; 1990 Aug; 37(1-2):21-3. PubMed ID: 2215828
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid in the treatment of chronic liver disease.
Cirillo NW; Zwas FR
Am J Gastroenterol; 1994 Sep; 89(9):1447-52. PubMed ID: 8079918
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic liver disease with ursodeoxycholic acid.
Guslandi M
J Int Med Res; 1990; 18(6):497-505. PubMed ID: 2292332
[TBL] [Abstract][Full Text] [Related]
18. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
Batts KP; Jorgensen RA; Dickson ER; Lindor KD
Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
[TBL] [Abstract][Full Text] [Related]
19. Immunologic effects of ursodeoxycholic acid in primary biliary cirrhosis.
Leevy CB; Holt J; Buniak B
J Assoc Acad Minor Phys; 1993; 4(1):30-2. PubMed ID: 8425102
[TBL] [Abstract][Full Text] [Related]
20. [Bile acid therapy; new hope for patients with chronic liver diseases].
van Berge Henegouwen GP; van Erpecum KJ
Ned Tijdschr Geneeskd; 1991 Apr; 135(16):696-700. PubMed ID: 2038392
[No Abstract] [Full Text] [Related]
[Next] [New Search]